Investigators have suggested that HLA hyperexpression may be an important first step in the development of type 1 diabetes.
Your new post is loading...
Your new post is loading...
Krishan Maggon 's curator insight,
October 21, 2014 3:24 PM
September 22, 2014 doi:10.4049/jimmunol.1400876 The Journal of ImmunologyNovember 1, 2014vol. 193 no. 9 4368-4380 Opposing Effects of CTLA4 Insufficiency on Regulatory versus Conventional T Cells in Autoimmunity Converge on Effector Memory in Target TissuePriyadharshini Devarajan*, Jason Miska*,1, Jen Bon Lui*, Dominika Swieboda* andZhibin Chen*,†+Author Affiliations *Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL 33136; and†Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL 33136+Author Notes ↵1 Current address: Department of Medicine, University of Chicago, Chicago, IL. Address correspondence and reprint requests to Dr. Zhibin Chen, Department of Microbiology and Immunology, University of Miami Miller School of Medicine, RMSB 3035, 1600 Northwest 10th Avenue, Miami, FL 33136. E-mail address: zchen@med.miami.edu
Remi Creusot's curator insight,
January 21, 2015 4:53 PM
Reduced CTLA-4 expression in a mouse with susceptible MHC but otherwise resistant according to other genes (the B6-g7 mouse) is sufficient to induce T1D in about 1/3 of the mice. CTLA-4 polymorphism is found in a number of subjects with T1D or a number of other autoimmune conditions... |
Krishan Maggon 's curator insight,
October 28, 2014 2:38 AM
Insulin like Growth factor 1 could suppress activated immune system in multiple sclerosis, slow down myelin destruction and delay disease progression. Active in EAE model, next step clinical trials.
open access EMBO Mol Med. 2014 Oct 22. pii: e201303376. doi: 10.15252/emmm.201303376. [Epub ahead of print]Insulin-like growth factor-1 stimulates regulatory T cells and suppresses autoimmune disease.Bilbao D1, Luciani L2, Johannesson B2, Piszczek A2, Rosenthal N3. |